|
|
|
. |
2000-2050
|
|
|
. |
|
|
|
|
|
.
|
.
|
|
NOTE:
To interpret
entries, please refer to the Forecast Key
below.
The information currently available from the FRC Track
pages is incomplete and in summary form. These public pages are intended for the general reader
and lack detailed information and analysis. To
submit feedback on any FRC Track forecast, or to learn
more about the detailed forecasts in the FRC
database, please contact us
at any time.
|
|
|
|
|
|
Medicine
Track
|
|
2000 |
|
|
|
2001 |
|
|
|
2002 |
|
|
|
2003 |
|
|
|
2004 |
|
|
|
2005 |
|
|
|
2006 |
|
|
|
2007 |
|
|
|
2008 |
|
|
|
2009 |
|
|
|
2010 |
|
10-01.
Genetic Engineering:
First genetic
therapies available for cancer. | P .8 Strong Positive: M, S
| |
|
2013 |
|
13-01.
Genetic Engineering: Gene
therapy will help eradicate inherited disease. | P .6 |
George Washington University
|
|
2015 |
|
|
|
2020 |
|
20-01.
Genetic Engineering: Parents
can routinely choose characteristics of their children through
genetic engineering. | P .5 | George Washington
University
|
|
2025 |
|
|
|
2030 |
|
|
|
2035 |
|
|
|
2040 |
|
|
|
2045 |
|
|
|
2050 |
|
|
|
|
Forecast Key
|
 |
|
FRC
Probability Estimates
|
|
P
.99
|
Forecast
is virtually (99%) certain.
|
|
P
.1
|
Forecast
has a 10% probability of realization.
|
|
T
=
|
If
the forecast is true, then <weak
/ moderate / strong> <positive
/ adverse> effects can be expected {in
Track(s) : <x>} |
.
|
|
|
|
|
|
|
.
|
|
|
| . |
. |
. |
| . |
. |
. |
| . |
. |
. |
| . |
.. |
. |
| . |
. |
|
|
